Expression of stress-response and cell proliferation genes in renal cell carcinoma induced by oxidative stress

American Journal of Pathology

Volumn 156, Issue 6, 2000, Pages 2149-2157

  Tanaka, T ^a   Kondo, S ^a   Iwasa, Y ^a   Hiai, H ^a   Toyokuni, S ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BINDING PROTEIN; CALDESMON; COMPLEMENTARY DNA; DNA POLYMERASE; HEAT SHOCK PROTEIN; LIPOCORTIN 2; NITRILOTRIACETATE IRON; PROTEIN TYROSINE PHOSPHATASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; RIBOSOME PROTEIN; SELENOPROTEIN; SOMATOMEDIN; TREFOIL PEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CARCINOGENESIS; CELL PROLIFERATION; CONTROLLED STUDY; FLUORESCENCE; GENE EXPRESSION; GENE ISOLATION; KIDNEY CARCINOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; PRIORITY JOURNAL; RAT;

EID: 0033869881     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)65085-7     Document Type: Article

References (66)

1. Oxidative stress ahd cancer: The role of redox regulation
2. Nephrotoxicity and renal cell carcinoma after use of iron- and aluminum-nitrilotriacetate complexes in rats
3. - renal cell carcinoma in mice treated with ferric nitrilotriacetate
4. Iron-induced tissue damage and cancer: The role of reactive oxygen free radicals
5. Iron-induced carcinogenesis: The role of redox regulation
6. Combined histochemical and biochemical analysis of sex hormone dependence of ferric nitrilotriacetate-induced renal lipid peroxidation in ddY mice
7. 7-12 acyloins in the kidney of Wistar rats after treatment with a renal carcinogen, ferric nitrilotriacetate
8. Formation of 4-hydroxy-2-nonenal-modified proteins in the renal proximal tubules of rats treated with a renal carcinogen, ferric nitrilotriacetate
9. A renal carcinogen ferric nitrilotriacetate mediates a temporary accumulation of aldehyde-modified proteins within cytosolic compartment of rat kidney
10. DNA base modifications in renal chromatin of Wistar rats, treated with a renal carcinogen, ferric nitrilo-triacetate
11. Treatment of Wistar rats with a renal carcinogen, ferric nitrilotriacetate, causes DNA-protein cross-linking between thymine and tyrosine in their renal chromatin
12. High incidence of allelic loss on chromosome 5 and inactivation of p15(INK4B) and p16 (INK4A) tumor suppressor genes in oxystress-induced renal cell carcinoma of rats
13. Low incidence of point mutations in H-, K- and N-ras oncogenes and p53 tumor suppressor gene in renal cell carcinoma and peritoneal mesothelioma of Wistar rats induced by ferric nitrilotriacetate
14. Induction of renal cell carcinoma in mate Wistar rats treated with cupric nitrilotriacetate
15. Establishment and characterization of three androgen-independent, metastatic carcinoma cell lines from 3,2'-dimethyl-4-aminobiphenyl-induced prostatic tumors in F344 rats
16. Induction and nuclear translocation of thioredoxin by oxidative damage in the mouse kidney: Independence of tubular necrosis and sulfhydryl depletion
17. The Y-box factors: A family of nucleic acid binding proteins conserved from Escherichia coli to man
18. A role for Y-box proteins in cell proliferation
19. Tissue-specific enhancer of the human multidrug-resistance (MDR1) gene
20. Puga: The Y-box motif mediates redox-dependent transcriptional activation in mouse cells
21. Activation of the oxyR transcription factor by reversible disulfide bond formation
22. Role of the human Y box-binding protein YB-1 in cellular sensitivity to the DNA-damaging agents cisplatin, mitomycin C, and ultraviolet light
23. Transcription factor Y-box binding protein 1 binds preferentially to cisplatin-modified DNA and interacts with proliferating cell nuclear antigen
24. Is nuclear expression of Y box-binding protein-1 a new prognostic factor in ovarian serous adenocarcinoma?
25. Hypothesis: Persistent oxidative stress in cancer
26. Over-expression of the S13 ribosomal protein in actively growing cells
27. High-level expression of the ribosomal protein L19 in human breast tumors that overexpress erbB-2
28. Identification of a human ribosomal protein mRNA with increased expression in colorectal tumours
29. Increased expression of human ribosomal phosphoprotein PO messenger RNA in hepatocelllular carcinoma and colon carcinoma
30. Several genes encoding ribosomal proteins are over-expressed in prostate-cancer cell lines: Confirmation of L7a and L37 over-expression in prostate-cancer tissue samples
31. Overproduction of mycobacterial ribosomal protein S13 induces catalase/peroxidase activity and hypersensitivity to isoniazid in Mycobacterium smegmatis
32. The effects of irradiation on the expression of a tumour rejection antigen (heat shock protein gp96) in human cervical cancer
33. Interleukin-6 upregulates GP96 expression in breast cancer
34. Human homologue of murine tumor rejection antigen gp96: 5'-regulatory and coding regions and relatonships to stress-induced proteins
35. Heat-shock proteins, Hsp84 and Hsp86. of mice and men: Two related genes encode formerly identified tumour-specific transplantation antigens
36. High constitutive transcription of HSP86 gene in murine embryonal carcinoma cells
37. Enhanced levels of annexins in pancreatic carcinoma cells of Syrian hamsters and their intrapancreatic allografts
38. Enhanced expression of the protein kinase substrate p36 in human hepatocellular carcinoma
39. Developmental regulation of annexin II (lipocortin 2) in human brain and expression in high grade glioma
40. Renal carcinogenesis in the Eker rat
41. The protein-tyrosine kinase substrate calpactin I heavy chain (p36), is part of the primer recognition protein complex that interacts with DNA polymerase α
42. The role of primer recognition proteins in DNA repllication: Inhibition of cellular proliferation by antisense oligodeoxyribonucleotides
43. Formation of the annexin II2p11(2) complex upon differentiation of F9 teratocarcinoma cells
44. Molecular cloning of rat calpactin I heavy-chain cDNA whose expression is induced in v-src-transformed rat culture cell lines
45. Localization of caldesmon and its dephosphorylation during cell division
46. Protein-tyrosine phosphatases: The other side of the coin
47. Protein tyrosine phosphatases: A diverse family of intracellular and transmembrane enzymes
48. Receptor protein-tyrosine phosphatase γ is a candidate tumor suppressor gene at human Chromosome region 3p21
49. Expression of a receptor protein tyrosine phosphatase in human glial tumors
50. Implication of a protein-tyrosine-phosphatase in human lung cancer
51. Multi-ligand interactions with receptor-like protein tyrosine phosphatase beta: Implications for intercellular signaling
52. A selenium-rich extracellular glycoprotein
53. Etiologic factors and pathologic alterations in selenium-vitamin E deficiency and excess in animals and humans
54. Identification and characterization of rat intestinal trefoil factor: Tissue- and cell-specific member of the trefoil protein family
55. The trefoil gene family are coordinately expressed immediate-early genes: EGF receptor- and MAP kinase-dependent interregulation
56. Intestinal trefoil factor controls the expression of the adenomatous polyposis coli-catenin and the E-cadherin-catenin complexes in human colon carcinoma cells
57. Expression and purification of a trefoil peptide motif in a β- galactosidase fusion protein and its use to search for trefoil-binding sites
58. Synthesis and characterization of insulin-like growth factor-binding protein (IGFBP)-7
59. Down-regulation of T1A12/mac25, a novel insulin-like growth factor binding protein related gene, is associated with desease progression in breast carcinomas
60. Impaired B-lymphopoiesis, myelopoiesis, and derailed cerebellar neuron migration in CXCR4- and SDF-1-deficient mice
61. The chemokine receptor CXCR4 is essential for vascularization of the gastrointestina tract
62. Two differentially expressed genes in normal human prostate tissue and in carcinoma
63. Identification of differentially expressed genes in T-lymphoid malignancies in an animal model system
64. Detection of mitochondrial genome depletion by a novel cDNA in renal cell carcinoma
65. Genomes with distinct function composition